Japanese encephalitis
Japanese encephalitis
IXIARO
Two doses, 28 days apart. Every product below is a Health Canada authorized vaccine; every schedule comes from the Canadian Immunization Guide.
Products authorized in Canada
Brand names and DINs (Drug Identification Numbers) as Health Canada's Drug Product Database lists them. The product monograph is the manufacturer's full prescribing information approved by Health Canada.
| Product | DIN | What it is | Presentation and age | Official information |
|---|---|---|---|---|
| IXIARO | 02333279 | Japanese encephalitis virus, inactivated (SA14-14-2) | 6 mcg / 0.5 mL · suspension · intramuscular · 2 months and older | Product guideHealth Canada recordProduct monograph (PDF) |
Pregnancy and breastfeeding
Pregnancy
Use if indicated for high-risk travel.
Breastfeeding
Use if indicated.
Source: Immunization in pregnancy and breastfeeding: Canadian Immunization Guide — Chapter updated August 2026. Live vaccines are generally contraindicated in pregnancy; routinely recommended vaccines can be given while breastfeeding unless the chapter says otherwise.
How many doses
The schedules the Canadian Immunization Guide describes for this vaccine. Which one applies depends on age, health and product — use the dose planner to see the dates for your situation.
| Schedule | Doses | Who it is for | Products |
|---|---|---|---|
| Japanese encephalitis (IXIARO) — two doses, 28 days apart Two doses 28 days apart, from 2 months of age; finished at least 1 week before travel. | 2 doses | Primary series of two doses 28 days apart. Adults 18 to 65 may use an accelerated day 0 and day 7 schedule when time is short. A booster 12 to 24 months after the primary series is recommended for continued risk. | IXIARO |
Sources
- Japanese encephalitis vaccine: Canadian Immunization Guide — Chapter revised September 2023 · partial update November 2024
- Health Canada Drug Product Database — product records and monographs
Clinical rules reviewed on 2026-09-27. General information from public Canadian guidance; a personal assessment is needed for treatment decisions. Care365 does not decide whether a vaccine is publicly funded in Ontario.